Tumor cell uptake and selectivity of gadolinium(III)-phosphonium complexes: The role of delocalisation at the phosphonium centre

被引:9
作者
Busse, Madleen [1 ]
Windsor, Madeline S. A. [1 ]
Tefay, Alexander J. [1 ]
Kardashinsky, Mingyue [1 ]
Fenton, Jacob M. [1 ]
Morrison, Daniel E. [1 ]
Harris, Hugh H. [2 ]
Rendina, Louis M. [1 ]
机构
[1] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia
[2] Univ Adelaide, Dept Chem, Adelaide, SA 5005, Australia
基金
澳大利亚研究理事会;
关键词
Gadolinium; Phosphonium; Glioblastoma; Mitochondria; XRF imaging; NEUTRON-CAPTURE THERAPY; DOUBLE-STRAND BREAKS; MOTEXAFIN-GADOLINIUM; CONTRAST AGENTS; IN-VITRO; BIODISTRIBUTION; RHODAMINE-123; MITOCHONDRIAL; ACCUMULATION; RETENTION;
D O I
10.1016/j.jinorgbio.2017.07.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The synthesis of a series of bifunctional Gd(III) complexes 1-3 covalently bound to arylphosphonium cations possessing a varying degree of delocalisation at the phosphonium centre is presented. The influence of the degree of delocalisation was investigated with regards to in vitro cytotoxicity, cellular uptake of Gd, tumor-cell selectivity and intracellular localisation of Gd within human glioblastoma (T98G) and human glial (SVG p12) cells. Cellular uptake and selectivity studies for the Gd(III) complexes indicate that a reduced delocalisation at the phosphonium centre can lead to an enhanced Gd uptake into SVG p12 cells which results in a decrease in the overall tumor cell selectivity. Synchrotron X-ray fluorescence (microbeam XRF) imaging has demonstrated for the first time that uniform uptake of Gd(III) complex 2 within a population of T98G cells increased as a function of increasing Gd incubation times. The Gd maps show dispersed spots of high intensity which are consistent with mitochondrial uptake.
引用
收藏
页码:313 / 321
页数:9
相关论文
共 45 条
  • [1] Biodistribution of Gadolinium-Based Contrast Agents, Including Gadolinium Deposition
    Aime, Silvio
    Caravan, Peter
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2009, 30 (06) : 1259 - 1267
  • [2] Strategies for increasing the sensitivity of gadolinium based MRI contrast agents
    Caravan, Peter
    [J]. CHEMICAL SOCIETY REVIEWS, 2006, 35 (06) : 512 - 523
  • [3] Crossley E. L., 2011, BIOINORGANIC MED CHE, P283
  • [4] Selective Aggregation of a Platinum-Gadolinium Complex Within a Tumor-Cell Nucleus
    Crossley, Ellen L.
    Aitken, Jade B.
    Vogt, Stefan
    Harris, Hugh H.
    Rendina, Louis M.
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2010, 49 (07) : 1231 - 1233
  • [5] DAVIS S, 1985, J BIOL CHEM, V260, P3844
  • [6] De Stasio C, 2001, CANCER RES, V61, P4272
  • [7] Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei
    De Stasio, G
    Rajesh, D
    Ford, JM
    Daniels, M
    Erhardt, R
    Frazer, BH
    Tyliszczak, T
    Gilles, MK
    Conhaim, RL
    Howard, SP
    Fowler, JF
    Estève, F
    Mehta, MP
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (01) : 206 - 213
  • [8] Are gadolinium contrast agents suitable for gadolinium neutron capture therapy?
    De Stasio, G
    Rajesh, D
    Casalbore, P
    Daniels, MJ
    Erhardt, RJ
    Frazer, BH
    Wiese, LM
    Richter, KL
    Sonderegger, BR
    Gilbert, B
    Schaub, S
    Cannara, RJ
    Crawford, JF
    Gilles, MK
    Tyliszczak, T
    Fowler, JF
    Larocca, LM
    Howard, SP
    Mercanti, D
    Mehta, MP
    Pallini, R
    [J]. NEUROLOGICAL RESEARCH, 2005, 27 (04) : 387 - 398
  • [9] F Armarego W.L., 2013, Purification of Laboratory Chemicals, VSeventh
  • [10] Faulkner S, 2015, CHEMISTRY OF MOLECULAR IMAGING, P179